DONALD PARSONS to Central Nervous System Neoplasms
This is a "connection" page, showing publications DONALD PARSONS has written about Central Nervous System Neoplasms.
Connection Strength
1.654
-
TRK inhibition for pediatric and adult central nervous system tumors: Early promise and future questions. Neuro Oncol. 2022 06 01; 24(6):1008-1009.
Score: 0.621
-
Applications of Genomic Sequencing in Pediatric CNS Tumors. Oncology (Williston Park). 2016 May; 30(5):411-23.
Score: 0.407
-
Mutant metabolic enzymes are at the origin of gliomas. Cancer Res. 2009 Dec 15; 69(24):9157-9.
Score: 0.262
-
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions. Clin Cancer Res. 2025 Feb 03; 31(3):561-572.
Score: 0.187
-
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors. J Clin Oncol. 2024 Aug 10; 42(23):2769-2779.
Score: 0.178